Clinical Trial Update: Efficacy and Safety Study of Human-cl rhFVIII in PTPs With Severe Hemophilia A [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating efficacy and safety of human-cl rhFVIII in patients with severe Hemophilia A has completed with posted results in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• rhFVIII (human-cl rhFVIII) (recombinant human Factor VIII)

Snippet

Sponsor: Octapharma | Conditions: Severe Hemophilia A | Phase 3 | Status: COMPLETED | Results posted: 2013-04-22